Measuring the subcellular compartmentalization of viral infections by protein complementation assay

Mesoscale polymer arrays: high aspect ratio surface structures and their digital reconstruction

Inspired by adhesive bio-filamentous structure, such as bacterial pili, this work details the methods used to fabricate and characterize a surface-anchored array of thin, flexible and shape-responsive mesoscale polymer ribbons with a length-to-thickness aspect ratio of up to 100 000. The resulting structures exhibit geometrically complex and dynamic morphologies consistent with elastocapillary bending that experience an increase in curvature over hours of aging due to creep. We develop a computational image analysis framework to generate 3D reconstructions of these densely crowded geometries and extract quantitative descriptors to demonstrate morphological changes due to aging. We demonstrate the robustness of this quantitative method by characterizing the creep-induced change in an aging ribbon array's shape and develop a scaling relationship to describe the importance of ribbon thickness for shape and dynamical observations. These methods demonstrate an essential baseline to probe morphology-property relationships of mesoscale polymer ribbon arrays fabricated from a variety of materials in numerous environments. Through the introduction of perfluorodecalin droplets, we illustrate the potential of these ribbon arrays towards applications in adhesive, microrobotic, and biomedical devices.

A new class of capsid-targeting inhibitors that specifically block HIV-1 nuclear import

HIV-1 capsids cross nuclear pore complexes (NPCs) by engaging with the nuclear import machinery. To identify compounds that inhibit HIV-1 nuclear import, we screened drugs in silico on a three-dimensional model of a CA hexamer bound by Transportin-1 (TRN-1). Among hits, compound H27 inhibited HIV-1 with a low micromolar IC50. Unlike other CA-targeting compounds, H27 did not alter CA assembly or disassembly, inhibited nuclear import specifically, and retained antiviral activity against PF74- and Lenacapavir-resistant mutants. The differential sensitivity of divergent primate lentiviral capsids, capsid stability and H27 escape mutants, together with structural analyses, suggest that H27 makes multiple low affinity contacts with assembled capsid. Interaction experiments indicate that H27 may act by preventing CA from engaging with components of the NPC machinery such as TRN-1. H27 exhibited good metabolic stability in vivo and was efficient against different subtypes and circulating recombinant forms from treatment-naïve patients as well as strains resistant to the four main classes of antiretroviral drugs. This work identifies compounds that demonstrate a novel mechanism of action by specifically blocking HIV-1 nuclear import.

Identifying enhancers of innate immune signaling as broad-spectrum antivirals active against emerging viruses

The increasingly frequent outbreaks of pathogenic viruses have underlined the urgent need to improve our arsenal of antivirals that can be deployed for future pandemics. Innate immunity is a powerful first line of defense against pathogens, and compounds that boost the innate response have high potential to act as broad-spectrum antivirals. Here, we harnessed localization-dependent protein-complementation assays (called Alpha Centauri) to measure the nuclear translocation of interferon regulatory factors (IRFs), thus providing a readout of innate immune activation following viral infection that is applicable to high-throughput screening of immunomodulatory molecules. As proof of concept, we screened a library of kinase inhibitors on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and identified Gilteritinib as a powerful enhancer of innate responses to viral infection. This immunostimulatory activity of Gilteritinib was found to be dependent on the AXL-IRF7 axis and results in a broad and potent antiviral activity against unrelated RNA viruses.